Skip to main content Accessibility help
×
Home

Cannabis affects the severity of schizophrenic symptoms: results of a clinical survey

  • Juan C. Negrete (a1), Werner P. Knapp (a1), Donald E. Douglas (a1) and W. Bruce Smith (a1)

Synopsis

Data on the history of cannabis use and a spot urine test for cannabinoids were obtained for 137 schizophrenics in treatment. Subjects who were using cannabis during the 6-month observation period presented with a significantly higher degree of delusional and hallucinatory activity than those who did not. Moreover, the group using cannabis made a higher average number of visits to the hospital during the same period. The status of cannabis use appeared to contribute to such variance more than did other relevant factors (age, stage of the illness, amount of medication prescribed, occasional use of other psychoactive substances).

Copyright

Corresponding author

1Address for correspondence: Professor J. C. Negrete, Department of Psychiatry, Montreal General Hospital, 1650 Cedar Avenue, Montreal, Canada H3G 1A4.

References

Hide All
Bernhardson, G. & Gunne, L. M. (1972). Forty six cases of psychosis in cannabis abusers. International Journal of Addiction 7, 916.
Davison, K. & Wilson, C. H. (1972). Psychosis associated with cannabis smoking. British Journal of Addiction 67, 225228.
Edwards, G. (1983). Psychopathology of a drug experience. British Journal of Psychiatry 143, 509512.
Harding, T. & Knight, F. (1973). Marihuana-modified mania. Archives of General Psychiatry 29, 635637.
Harrow, M., Carone, B. J. & Westermeyer, J. F. (1985). The course of psychosis in early phases of schizophrenia. American Journal of Psychiatry 142, 702707.
Knudsen, P. & Vilmar, T. (1984). Cannabis and neuroleptic agents in schizophrenia. Acta Psychiatrica Scandinavica 69, 162174.
Magliozzi, J. R., Kanter, S. L., Csernansky, J. G. & Hollister, L. E. (1983). Detection of marijuana use in psychiatric patients by determination of urinary delta-9-tetrahydro-cannabinol-ll-oic acid. Journal of Nervous and Mental Disease 171, 246249.
Melges, F. T. (1976). Tracking difficulties and paranoid ideation during hashish and alcohol intoxication. American Journal of Psychiatry 133, 10241028.
Negrete, J. C. (1983). Psychiatric effects of cannabis use. In Cannabis and Health Hazards (ed. Fehr, K. and Kalant, H.), pp. 577616. Addiction Research Foundation: Toronto.
Negrete, J. C. (1985). Clinical psychiatric complications of cannabis use: an update. In Marihuana '84: Proceedings of the Oxford Symposium on Cannabis (ed. Harvey, D. J. and Paton, W.), pp. 581592. IRL Press: Oxford.
O'Conner, J. D. & Regent, T. A. (1981). EMIT cannabinoid assay: confirmation by RIA and GC/MS. Journal of Analysis and Toxicology 5, 168173.
Rottanburg, D., Robins, A. H., Ben-Arie, O., Teggin, A. & Elk, R. (1982). Cannabis-associated psychosis with hypomanic features. Lancet ii, 13641366.
Schneider, H. (1976). Drug abuse and schizophrenia. Archiv für Psychiatrie und Nervenkrankheiten 222 (2–3), 267279.
Tashner, K. L. (1983). Zur Psychopathologie und Differential-diagnose sogennanter cannabis Psychosen (Psychopathology and differential diagnosis of the so-called cannabis psychosis). Fortschritte der Neurologie und Psychiatrie 51 (7), 235248.
Treffert, D. A. (1978). Marijuana use in schizophrenia: a clear hazard. American Journal of Psychiatry 135, 12131215.
Westermeyer, J. & Walzer, U. (1975). Sociopathy and drug use in a young psychiatric population. Diseases of the Nervous System 36, 673677.

Cannabis affects the severity of schizophrenic symptoms: results of a clinical survey

  • Juan C. Negrete (a1), Werner P. Knapp (a1), Donald E. Douglas (a1) and W. Bruce Smith (a1)

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed